E xperimental studies in animals demonstrate that neutrophils play important roles in the pathophysiology of myocardial ischemia and infarction.1-5 Several epidemiologic studies in human subjects also indicate the relevance of leukocytes in ischemic heart disease. Elevation of leukocyte count in peripheral blood is associated with increased risk of acute myocardial infarction,6-10 its recurrence,1 and the incidence of ventricular fibrillation in the postinfarction period.12 Leukocyte count has also been shown to correlate with the extent of coronary artery disease observed at coronary angiography.13
After ischemic injury, neutrophils rapidly accumulate in the areas of injury.14 After migration into these areas, neutrophils discharge oxygen-free radicals,15 proteolytic enzymes, and arachidonic acid metabolites, such as leukotriene B4 (LTB4).2 Neutrophil activation is relevant in "reperfusion injury'"1617 and loss of coronary vasodilator reserve after reperfusion. 18 Although peripheral neutrophil activation has been shown to correlate with the severity of ischemic heart disease in humans in one study,19 very little is known about the functional characteristics of neutrophils in patients with ischemic heart disease. In our study, we examine several aspects of neutrophil function to determine neutrophil activity in various forms of ischemic heart disease.
Methods

Subjects
All control subjects and patients were men. Twenty patients with angiographically documented coronary artery disease (CAD) and stable angina pectoris, 17 patients with unstable angina pectoris or acute myocardial infarction (AMI), and 20 control subjects participated in this study, which was approved by the 
Neutrophil Elastase Release
A vasoactive peptide (Arg-Pro-Ala-Pro-ProPro-Ile-Ser-Gly-Gly-Gly-Tyr-Arg-Ala), produced by the action of elastase on fibrin(ogen) and corresponding to amino acids 30-43 of the fibrinogen B,B chain, was synthesized; antibodies were raised in rabbits; and an RIA was developed.23'24 The antibody obtained exhibited both high specificity and high sensitivity to peptides released by neutrophil elastase degradation of the B,3 chain of fibrin(ogen).
Peptides released by plasmin, trypsin, chymotrypsin, collagen, thrombin, or pancreatic elastase degradation do not react with the antibodies. The cross-reaction with fibrinogen is extremely low (less than 2%). The only cross-reaction of importance is against a larger peptide fragment, a precursor to B,8 30-43, released by degradation of fibrin(ogen) by neutrophil elastase. This fragment is very stable in plasma and is in fact responsible for most (or all) of the immunoreactivity in human plasma.
The detection limit of this RIA is 30-50 pmol/l. Normal human plasma concentration of this peptide varies between 0 and 120 pmol/1.23,24 The individuals performing the measurement of peptide B,B in plasma (T.G.P.S. and R.W.) were kept blinded as to the clinical diagnosis of patients.
Electron Microscopy
Isolated neutrophils were centrifuged into a button in a conical tube, fixed in 1% glutaraldehyde/4% formalin solution, postfixed in 1% osmium tetroxide, and then set in an agar button. Most of the agar was cut from around the fixed button, which was then dehydrated through graded alcohols and acetone before embedding in eponaraldite during over- As shown in Figure 3, also increased, but the stimulated activity (in response to f-MLP) was often decreased particularly in instances where the yield of cells was low and clumping of cells was visually evident. In light of previous in vivo activation, it was not surprising that the chemotactic response of these neutrophils and their potential to generate LTB4 were not increased upon further stimulation. It is also likely that active neutrophils were preferentially trapped in the coronary circulation, and less active neutrophils in peripheral circulation had normal or subnormal functional characteristics. It can be speculated that spontaneous trapping of neutrophils in coronary circulation may be detrimental by occluding small arterioles and inducing endothelial injury via release of free oxygen radicals.
A striking and novel observation in this study is the increase in neutrophil elastase release. In some recent reviews.35,36 the contributory role of neutrophils in the propagation of myocardial injury after coronary occlusion has been emphasized. Neutro 10`8 M) enhanice human neutrophil superoxide production, and small concentrations of lipopolysaceharide (100 ng/ml) increase neutrophil PAF production. We previously showed that platelets stimulate human neutrophil chemotaxis, LTB4 generation, and freeoxygen radical release,2' and leukocyte-derived peptido-leukotrienes stimulate platelets "primed" with epinephrine.311 The "hyperactivity of neutrophils in vitro in patients with stable CAD demonstrated in this study may also relate to "priming" of cells in response to PAF, hyperactive platelets. or some other stimuli. 21, 30143 Regardless of the precise stimulus, enhanced neutrophil activity in stable CAD may provide a pathophysiologic milieu for the progression of stable CAD to unstable myocardial ischemia. It is conceivable that patients who develop acute myocardial ischemia have abnormal leukocyte function before the onset of acute event.
Neutrophil-mediated endothelial damage may allow alterations in vasomotor tone. Furthermore, enhanced neutrophil activity may result in neutrophil plugging and subsequent decreases in myocardial compliance characteristic with concomitant loss of myocardial function .2 16-18, 35,36 In summary, this study demonstrates qualitative and quantitative changes in neutrophil function that may have important implications in the development and consequences of CAD.
